type here...

CATEGORIES

Patient Zone

LATEST

1...456...60Page 5 of 60

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

My First Time Operating as an Intern Was Eye-Opening

Simona Cazanescu -
The very real life experience of a medical student experiencing their first call to surgery. The feelings that accompany being on the other side of the knife for the first time

Dairy Fats Reduce Your Risk of Heart Attack, New Study Finds

Medika Life -
Increased levels of dairy fat have been shown to reduce the risk of heart attack and death, according to new research from Sweden

Wadhwani Foundation $1 Million In Grants for Covid Families in India

Medika Life -
Wadhwani Foundation Announces $1 Million In Grants To Immediately Help Indian Families Impacted By Covid-19. Donations to 10 charities and organizations will provide medical and financial assistance to patients and families to help reduce the devastating impact and slow COVID-19 spread.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories